Fecal microbiota of dogs supplemented with a probiotic
The goal is to evaluate the impact of supplementation with a combined probiotic (B. subtilis 597, B. subtilis 600, and B. amyloliquefaciens 516) on the fecal microbiota and health outcomes of dogs. A crossover experiment was composed of a 21-d adaptation period, two 28-d experimental periods, and a 21-d washout period that separated the experimental periods. In the first experimental period, 10 dogs were allotted to the control group (3-4 g of maltodextrin) and 10 dogs were allotted to the probiotic group. In the second experimental period, dogs were allotted to the opposite treatment group.